NASDAQ Biotechnology Index — американский фондовый индекс. Индекс составляют биотехнологические и фармацевтические компании, чьи акции торгуются на бирже NASDAQ.

Критерии

Критерии включения в NASDAQ Biotechnology Index:

• Компания должна иметь листинг на бирже NASDAQ.

• Компания должна относиться либо к биотехнологической, либо к фармацевтической отрасли.

• Компания не должна быть в процессе банкротства.

• Рыночная капитализация не менее $200 млн.

• Средний ежедневный объём торгов — 100 тысяч акций.

• Акции компании должны котироваться на биржах не менее 6 месяцев

Компоненты

В индекс входят следующие компании:

• Acorda Therapeutics Inc. (NASDAQ: ACOR)

• Adolor Corporation (NASDAQ: ADLR)

• Affymetrix Inc. (NASDAQ: AFFX)

• Akorn Inc. (NASDAQ: AKRX)

• Albany Molecular Research Inc. (NASDAQ: AMRI)

• Alexion Pharmaceuticals Inc. (NASDAQ: ALXN)

• Alexza Pharmaceuticals Inc. (NASDAQ: ALXA)

• Alkermes Inc. (NASDAQ: ALKS)

• Allos Therapeutics Inc. (NASDAQ: ALTH)

• Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY)

• AMAG Pharmaceuticals Inc. (NASDAQ: AMAG)

• Amgen Inc. (NASDAQ: AMGN)

• Amylin Pharmaceuticals Inc. (NASDAQ: AMLN)

• Arena Pharmaceuticals Inc. (NASDAQ: ARNA)

• ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA)

• ArQule Inc. (NASDAQ: ARQL)

• Array BioPharma Inc. (NASDAQ: ARRY)

• Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL)

• BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)

• Biodel Inc. (NASDAQ: BIOD)

• Biogen Idec Inc. (NASDAQ: BIIB)

• BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)

• BioMimetic Therapeutics Inc. (NASDAQ: BMTI)

• BMP Sunstone Corporation (NASDAQ: BJGP)

• Cadence Pharmaceuticals Inc. (NASDAQ: CADX)

• Cardiome Pharma Corporation (NASDAQ: CRME)

• Celera Corporation (NASDAQ: CRA)

• Celgene Corporation (NASDAQ: CELG)

• Cephalon Inc. (NASDAQ: CEPH)

• Columbia Laboratories Inc. (NASDAQ: CBRX)

• Crucell NV (NASDAQ: CRXL)

• Cubist Pharmaceuticals Inc. (NASDAQ: CBST)

• Cypress Bioscience Inc. (NASDAQ: CYPB)

• Cytokinetics Incorporated (NASDAQ: CYTK)

• Dendreon Corporation (NASDAQ: DNDN)

• DepoMed Inc. (NASDAQ: DEPO)

• Discovery Laboratories Inc. (NASDAQ: DSCO)

• Durect Corporation (NASDAQ: DRRX)

• Dyax Corporation (NASDAQ: DYAX)

• Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP)

• Enzon Pharmaceuticals Inc. (NASDAQ: ENZN)

• Exelixis Inc. (NASDAQ: EXEL)

• Facet Biotech Corporation (NASDAQ: FACT)

• Flamel Technologies S.A. (NASDAQ: FLML)

• Gen-Probe Incorporated (NASDAQ: GPRO)

• Genomic Health Inc. (NASDAQ: GHDX)

• Genzyme Corporation (NASDAQ: GENZ)

• Geron Corporation (NASDAQ: GERN)

• Gilead Sciences Inc. (NASDAQ: GILD)

• GTx Inc. (NASDAQ: GTXI)

• Halozyme Therapeutics Inc. (NASDAQ: HALO)

• Human Genome Sciences Inc. (NASDAQ: HGSI)

• Idenix Pharmaceuticals Inc. (NASDAQ: IDIX)

• Illumina Inc. (NASDAQ: ILMN)

• ImmunoGen Inc. (NASDAQ: IMGN)

• Immunomedics Inc. (NASDAQ: IMMU)

• Impax Laboratories Inc. (NASDAQ: IPXL)

• Incyte Corporation (NASDAQ: INCY)

• Inspire Pharmaceuticals Inc. (NASDAQ: ISPH)

• InterMune Inc. (NASDAQ: ITMN)

• Isis Pharmaceuticals Inc. (NASDAQ: ISIS)

• Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX)

• Life Technologies Corporation (NASDAQ: LIFE)

• Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

• Luminex Corporation (NASDAQ: LMNX)

• MannKind Corporation (NASDAQ: MNKD)

• Matrixx Initiatives Inc. (NASDAQ: MTXX)

• Maxygen Inc. (NASDAQ: MAXY)

• Medarex Inc. (NASDAQ: MEDX)

• Medivation Inc. (NASDAQ: MDVN)

• Micromet Inc. (NASDAQ: MITI)

• MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK)

• Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

• Mylan Inc. (NASDAQ: MYL)

• Myriad Genetics Inc. (NASDAQ: MYGN)

• Nabi Biopharmaceuticals (NASDAQ: NABI)

• Nektar Therapeutics (NASDAQ: NKTR)

• Neurocrine Biosciences Inc. (NASDAQ: NBIX)

• Novavax Inc. (NASDAQ: NVAX)

• Noven Pharmaceuticals Inc. (NASDAQ: NOVN)

• NPS Pharmaceuticals Inc. (NASDAQ: NPSP)

• Obagi Medical Products Inc. (NASDAQ: OMPI)

• ONYX Pharmaceuticals Inc. (NASDAQ: ONXX)

• Optimer Pharmaceuticals Inc. (NASDAQ: OPTR)

• Orexigen Therapeutics Inc. (NASDAQ: OREX)

• OSI Pharmaceuticals Inc. (NASDAQ: OSIP)

• Osiris Therapeutics Inc. (NASDAQ: OSIR)

• Pain Therapeutics (NASDAQ: PTIE)

• PDL BioPharma Inc. (NASDAQ: PDLI)

• Perrigo Company (NASDAQ: PRGO)

• Pharmasset Inc. (NASDAQ: VRUS)

• Pozen Inc. (NASDAQ: POZN)

• Progenics Pharmaceuticals Inc. (NASDAQ: PGNX)

• Qiagen N.V. (NASDAQ: QGEN)

• QLT Inc. (NASDAQ: QLTI)

• Questcor Pharmaceuticals Inc. (NASDAQ: QCOR)

• Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)

• Rigel Pharmaceuticals Inc. (NASDAQ: RIGL)

• Salix Pharmaceuticals Ltd. (NASDAQ: SLXP)

• Sangamo BioSciences Inc. (NASDAQ: SGMO)

• Santarus Inc. (NASDAQ: SNTS)

• Savient Pharmaceuticals Inc (NASDAQ: SVNT)

• Seattle Genetics Inc. (NASDAQ: SGEN)

• Sepracor Inc (NASDAQ: SEPR)

• Sequenom Inc. (NASDAQ: SQNM)

• Shire plc (NASDAQ: SHPGY)

• StemCells Inc. (NASDAQ: STEM)

• SuperGen Inc. (NASDAQ: SUPG)

• Synta Pharmaceuticals Corp. (NASDAQ: SNTA)

• Techne Corporation (NASDAQ: TECH)

• Teva Pharmaceutical Industries Limited (NASDAQ: TEVA)

• The Medicines Company (NASDAQ: MDCO)

• Theravance Inc. (NASDAQ: THRX)

• United Therapeutics Corporation (NASDAQ: UTHR)

• Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

• ViroPharma Incorporated (NASDAQ: VPHM)

• Vivus Inc. (NASDAQ: VVUS)

• Warner Chilcott Limited (NASDAQ: WCRX)

• XenoPort Inc. (NASDAQ: XNPT)

• XOMA Ltd. (NASDAQ: XOMA)

• ZymoGenetics Inc. (NASDAQ: ZGEN)

Источник: http://ru.wikipedia.org/wiki/NASDAQ_Biotechnology_Index